ISOLF — Isodiol International Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $3.13m
- CA$22.25m
Annual cashflow statement for Isodiol International, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.913 | -8.68 | -4.29 | -36 | -121 |
Depreciation | |||||
Non-Cash Items | 0.248 | 7.08 | 1.65 | 16.5 | 95.9 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.032 | 0.067 | -0.201 | -5.01 | -1.43 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.633 | -1.53 | -2.84 | -23.5 | -24 |
Capital Expenditures | — | — | -0.388 | -7.06 | -4.48 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | -9.59 | -12 |
Acquisition of Business | |||||
Sale of Business | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | — | -0.388 | -16.6 | -16.5 |
Financing Cash Flow Items | 0 | 0.255 | -0.05 | -1.57 | -0.48 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.648 | 1.62 | 3.84 | 55.1 | 24.7 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.015 | 0.091 | 0.613 | 14.8 | -15.1 |